Literature DB >> 22959968

Laparoscopic adrenalectomy for co-secreting aldosterone and cortisol adenomas.

C R Lobo1, A Kolinioti, A J Hainsworth, G Bano, S S Mudan, A K Sharma.   

Abstract

There are few published data on aldosterone and cortisol co-secreting adrenal tumours. Failure to perform comprehensive preoperative endocrine investigations in patients with adrenal "incidentalomas" or in those thought to be secreting only one hormone may account for this. Clinically patients with such lesions may have evidence of hypertension and hypokalaemia with no features of cortisol excess. Preoperative diagnosis of such lesions with accurate endocrinological work up is essential to prevent adrenal insufficiency and haemodynamic crises following removal of such glands. We present a series of 4 patients with co-secreting tumours treated by laparoscopic adrenalectomy between September 2010 and March 2011. Our experience suggests that dual secretors are more common than originally thought. A high index of suspicion and adequate endocrine work up is paramount in diagnosing such tumours and in experienced hands, laparoscopic adrenalectomy with appropriate substitutive steroid cover is safe, feasible and curative for these functioning adrenal tumours.
Copyright © 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22959968     DOI: 10.1016/j.ijsu.2012.08.017

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  2 in total

1.  Adrenal Vein Cortisol to Metanephrine Ratio for Localizing ACTH-Independent Cortisol-Producing Adenoma: A Case Report.

Authors:  Rishi Raj; Philip A Kern; Neelima Ghanta; Edilfavia M Uy; Kamyar Asadipooya
Journal:  J Endocr Soc       Date:  2021-01-25

2.  Adrenal venous sampling in patients with ACTH-independent hypercortisolism.

Authors:  Eleni Papakokkinou; Hugo Jakobsson; Augustinas Sakinis; Andreas Muth; Bo Wängberg; Olof Ehn; Gudmundur Johannsson; Oskar Ragnarsson
Journal:  Endocrine       Date:  2019-08-22       Impact factor: 3.633

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.